A
Autolus Therapeutics plc D
D
AUTL
2.97500
USD
0.05
(1.54%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-2
Market Cap
791,712,025
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Autolus Therapeutics plc
Sector: Healthcare
Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3,AUTO5, AUTO6, AUTO7 & AUTO8.